Feasibility evaluation of hypofractionated radiotherapy with concurrent temozolomide in elderly patients with glioblastoma

被引:0
|
作者
Megumi Uto
Takashi Mizowaki
Kengo Ogura
Yoshiki Arakawa
Yohei Mineharu
Susumu Miyamoto
Masahiro Hiraoka
机构
[1] Graduate School of Medicine,Department of Radiation Oncology and Image
[2] Kyoto University,Applied Therapy
[3] Graduate School of Medicine,Department of Neurosurgery
[4] Kyoto University,undefined
来源
International Journal of Clinical Oncology | 2016年 / 21卷
关键词
Glioblastoma; Elderly; Hypofractionated radiotherapy; Temozolomide;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1023 / 1029
页数:6
相关论文
共 50 条
  • [21] Hypofractionated chemoradiotherapy with temozolomide as a treatment option for glioblastoma patients with poor prognostic features
    Lim, Yu Jin
    Kim, Il Han
    Han, Tae Jin
    Choi, Seung Hong
    Park, Sung-Hye
    Park, Chul-Kee
    Paek, Sun Ha
    Lee, Se-Hoon
    Kim, Tae Min
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (01) : 21 - 28
  • [22] Hypofractionated chemoradiotherapy with temozolomide as a treatment option for glioblastoma patients with poor prognostic features
    Yu Jin Lim
    Il Han Kim
    Tae Jin Han
    Seung Hong Choi
    Sung-Hye Park
    Chul-Kee Park
    Sun Ha Paek
    Se-Hoon Lee
    Tae Min Kim
    International Journal of Clinical Oncology, 2015, 20 : 21 - 28
  • [23] Postoperative radiotherapy and concomitant temozolomide for elderly patients with glioblastoma
    Gerstein, Johanna
    Franz, Kea
    Steinbach, Joachim P.
    Seifert, Valker
    Fraunholz, Inge
    Weiss, Christian
    Roedel, Claus
    RADIOTHERAPY AND ONCOLOGY, 2010, 97 (03) : 382 - 386
  • [24] Treatment outcomes of hypofractionated radiotherapy combined with temozolomide followed by bevacizumab salvage therapy in glioblastoma patients aged > 75 years
    Matsuda, Ken-ichiro
    Sakurada, Kaori
    Nemoto, Kenji
    Kayama, Takamasa
    Sonoda, Yukihiko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (05) : 820 - 825
  • [25] Hypofractionated intensity-modulated radiotherapy using simultaneous integrated boost technique with concurrent and adjuvant temozolomide for glioblastoma
    Yoon, Sang Min
    Kim, Jeong Hoon
    Kim, Sang Joon
    Khang, Shin Kwang
    Shin, Seong Soo
    Cho, Young Hyun
    Jwa, Eunjin
    Park, Jin-hong
    Ahn, Seung Do
    TUMORI, 2013, 99 (04) : 480 - 487
  • [26] A Model to Predict the Feasibility of Concurrent Chemoradiotherapy With Temozolomide in Glioblastoma Multiforme Patients Over Age 65
    Putz, Florian
    Knippen, Stefan
    Lahmer, Godehard
    Fietkau, Rainer
    Semrau, Sabine
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2017, 40 (05): : 523 - 529
  • [27] Toxicity and Outcome of Radiotherapy with Concomitant and Adjuvant Temozolomide in Elderly Patients with Glioblastoma: A Retrospective Study
    Saito, Kuniaki
    Mukasa, Akitake
    Narita, Yoshitaka
    Tabei, Yusuke
    Shinoura, Nobusada
    Shibui, Soichiro
    Saito, Nobuhito
    NEUROLOGIA MEDICO-CHIRURGICA, 2014, 54 (04) : 272 - 279
  • [28] Radiotherapy Plus Concurrent or Sequential Temozolomide for Glioblastoma in the Elderly: A Meta-Analysis
    Yin, An-an
    Zhang, Lu-hua
    Cheng, Jin-xiang
    Dong, Yu
    Liu, Bo-lin
    Han, Ning
    Zhang, Xiang
    PLOS ONE, 2013, 8 (09):
  • [29] ACCELERATED HYPOFRACTIONATED INTENSITY-MODULATED RADIOTHERAPY WITH CONCURRENT AND ADJUVANT TEMOZOLOMIDE FOR PATIENTS WITH GLIOBLASTOMA MULTIFORME: A SAFETY AND EFFICACY ANALYSIS
    Panet-Raymond, Valerie
    Souhami, Luis
    Roberge, David
    Kavan, Petr
    Shakibnia, Lily
    Muanza, Thierry
    Lambert, Christine
    Leblanc, Richard
    Del Maestro, Rolando
    Guiot, Marie-Christine
    Shenouda, George
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (02): : 473 - 478
  • [30] Temozolomide Concomitant and Adjuvant to Radiotherapy in Elderly Patients With Glioblastoma Correlation With MGMT Promoter Methylation Status
    Brandes, Alba A.
    Franceschi, Enrico
    Tosoni, Alicia
    Benevento, Francesca
    Scopece, Luciano
    Mazzocchi, Valeria
    Bacci, Antonella
    Agati, Raffaele
    Calbucci, Fabio
    Ermani, Mario
    CANCER, 2009, 115 (15) : 3512 - 3518